The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 51 results:
Author Title [ Type(Asc)] Year
Filters: Author is Gavriilaki, Eleni  [Clear All Filters]
Journal Article
Gavriilaki, E., Gkaliagkousi E., & Douma S. (2015).  Visit-to-visit blood pressure variability: more to come.. J Clin Hypertens (Greenwich). 17(2), 116-7.
Sousos, N., Gavriilaki E., Vakalopoulou S., & Garipidou V. (2016).  Understanding cardiovascular risk in hemophilia: A step towards prevention and management.. Thromb Res. 140, 14-21.
Gavriilaki, E., Tsiftsoglou S. A., Touloumenidou T., Farmaki E., Panagopoulou P., Michailidou E., et al. (2022).  Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.. Curr Issues Mol Biol. 44(7), 2811-2824.
Vlachaki, E., Gavriilaki E., Kafantari K., Adamidou D., Tsitsikas D., Chasapopoulou E., et al. (2018).  Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.. Hemoglobin. 42(5-6), 339-341.
Gavriilaki, E., Sabanis N., Paschou E., Grigoriadis S., Mainou M., Gaitanaki A., et al. (2013).  Splenic infarction as a rare complication of infectious mononucleosis due to Epstein-Barr virus infection in a patient with no significant comorbidity: case report and review of the literature.. Scand J Infect Dis. 45(11), 888-90.
Triantafyllou, A., Gavriilaki E., & Douma S. (2012).  Retinopathy assessment in hypertension is still puzzling.. Am J Hypertens. 25(7), 726.
Gkaliagkousi, E., Gavriilaki E., & Douma S. (2014).  Reply to: Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.. J Clin Hypertens (Greenwich). 16(10), 769.
Chatzidimitriou, M., Chatzopoulou F., Gavriilaki E., Chatzivasileiou P., Rousis D., Meletis G., et al. (2020).  Repeated negative serological testing in otherwise healthy patients with COVID-19.. J Infect Dis.
Gkaliagkousi, E., Gavriilaki E., Triantafyllou G., Nikolaidou B., & Douma S. (2014).  The putative role of vitamin D in essential hypertension: stepping into the light?. Am J Hypertens. 27(7), 985-6.
Gavriilaki, E., Christodoulou I., Koravou E-E., Paleta A., Koutra M., Zerva P., et al. (2018).  Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia.. Hemasphere. 2(5), e58.
Gavriilaki, E., Gkaliagkousi E., & Douma S. (2015).  Platelets interplay between pneumonia and cardiovascular events: establishing a link?. J Am Coll Cardiol. 65(14), 1487-8.
Gkaliagkousi, E., Gavriilaki E., Yiannaki E., Markala D., Papadopoulos N., Triantafyllou A., et al. (2014).  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.. Am J Hypertens. 27(4), 571-8.
Gkaliagkousi, E., Gavriilaki E., Triantafyllou A., & Douma S. (2016).  PATHWAY-2: spironolactone for resistant hypertension.. Lancet. 387(10026), 1372.
Gavriilaki, E., Chatzidimitriou D., Chatzopoulou F., Gkaliagkousi E., & Douma S. (2013).  Pathogen burden and hypertension: more questions than answers.. Am J Hypertens. 26(12), 1459.
Nikolaidou, B., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., Zarifis H., et al. (2022).  Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.. J Hum Hypertens. 36(9), 805-810.
Sakellari, I., Gavriilaki E., Papagiannopoulos S., Gavriilaki M., Batsis I., Mallouri D., et al. (2019).  Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.. J Neurol. 266(8), 1960-1972.
Gavriilaki, M., Mainou M., Gavriilaki E., Haidich A-B., Papagiannopoulos S., Sakellari I., et al. (2019).  Neurologic complications after allogeneic transplantation: a meta-analysis.. Ann Clin Transl Neurol. 6(10), 2037-2047.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2015).  Mean platelet volume in hypertensive urgencies and emergencies: opening the Pandora's Box.. Platelets. 26(3), 275-6.
Gavriilaki, E., Kirmizis D., & Chatzidimitriou D. (2013).  Letter by Gavriilaki et al regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".. Circulation. 128(15), e236.
Douma, S., Kamparoudis A., Petidis K., Anyfanti P., Doumas M., Gkaliagkousi E., et al. (2012).  Leiomyosarcoma of renal vein, initially resembling pheochromocytoma.. Clin Exp Hypertens. 34(6), 429-31.
Nikolaidou, B., Gkaliagkousi E., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., et al. (2020).  The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II.. BMC Nephrol. 21(1), 119.
Anyfanti, P., Gkaliagkousi E., Triantafyllou A., Koletsos N., Gavriilaki E., Galanopoulou V., et al. (2020).  Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines.. J Hum Hypertens.
Varelas, C., Gavriilaki E., Sakellari I., Klonizakis F., Anagnostopoulos A., Tsapas A., et al. (2022).  Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.. Hemoglobin. 46(2), 143-145.
Asteris, P. G., Gavriilaki E., Touloumenidou T., Koravou E-E., Koutra M., Papayanni P. Georgia, et al. (2022).  Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks.. J Cell Mol Med. 26(5), 1445-1455.
Gavriilaki, E., Asteris P. G., Touloumenidou T., Koravou E-E., Koutra M., Papayanni P. Georgia, et al. (2021).  Genetic justification of severe COVID-19 using a rigorous algorithm.. Clin Immunol. 226, 108726.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.